THE IMPACT OF UTERINE FIBROMATOSIS ON THE ENDOMETRIUM AND FERTILITY

  • F.D. Calin Department of Obstetrics and Gynecology, “St. Pantelimon” Emergency Clinical Hospital, Bucharest, Romania; “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • C.A. Ionescu Department of Obstetrics and Gynecology, “St. Pantelimon” Emergency Clinical Hospital, Bucharest, Romania; “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • M.C.T. Dimitriu Department of Obstetrics and Gynecology, “St. Pantelimon” Emergency Clinical Hospital, Bucharest, Romania; “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • A.M. Ciobanu Department of Obstetrics and Gynecology, “St. Pantelimon” Emergency Clinical Hospital, Bucharest, Romania
  • C.D. Badiu “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of General Surgery, "Bagdasar Arseni" Emergency Clinical Hospital, Bucharest, Romania
  • A. Neacșu “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Obstetrics, Gynecology and Neonatology, “St. Ioan” Emergency Clinical Hospital, Bucharest, Romania
  • B. Socea “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of General Surgery, "Bagdasar Arseni" Emergency Clinical Hospital, Bucharest, Romania
  • D. Hudiță “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania ; Department of Obstetrics and Gynecology, “Dr. I. Cantacuzino” Clinical Hospital, Bucharest, Romania
Keywords: uterine fibroid, endometrium in fibromatosis, fertility, sterility

Abstract

Uterine fibroids are the most common benign tumor that can be found in a woman's reproductive
system. The uterine fibroid affects millions of women globally each year and we can consider this
pathology, without exaggerating, an important public health problem. Our study was carried out
prospectively, in 5 years (2015-2019) and enrolled 480 patients selected with uterine fibroid, from a
number of 28809 women who were hospitalized during this period in the university clinic of
Obstetrics and Gynecology within the „Saint Pantelimon” Emergency Hospital, Bucharest, Romania.
Patients were divided into two groups of study: Group A, those with well-defined, single or multiple
uterine fibroid and Group B – patients with diffuse uterine fibromatosis. The clinical,
histopathological and immunohistochemical study analyzed and monitored over time, by comparison
between the two groups, 52 parameters for each patient, starting with the usual epidemiological
factors (age, weight, height, body mass index, personal or family medical history, etc.), continuing
with those related to fertility and other clinical issues (chronic pain, metrorrhagia, number of births,
recurrent miscarriage, etc.), up to intraoperative parameters (duration of surgery, blood loss, pelvic
drainage, the need for blood transfusion) and finally, histopathological aspects. We present in this
article some of the results of our study, those related to the quality of the endometrium in the
fibromatous uterus and the influence that uterine fibroid had on the fertility of our patients.

References

[1] Lippman SA, et al. Uterine fibroids and
gynecologic pain symptoms in a population-based
study. Fertil Steril. 2003; 80(6):1488–1494.
[PubMed: 14667888].
[2] Ryan GL, Syrop CH, Van Voorhis BJ. Role,
epidemiology, and natural history of benign uterine
mass lesions. Clin Obstet Gynecol. 2005; 48:312–
324.
[3] Baird DD, et al. High cumulative incidence of
uterine leiomyoma in black and white women:
ultrasound evidence. Am J Obstet Gynecol. 2003;
188(1):100–107. [PubMed: 12548202].
51
[4] F.D. Călin, M.C.T. Dimitriu, Ana Maria Ciobanu,
Teodora Vlădescu, C.A. Ionescu, D. Hudiţă. Uterine
fibroid and diffuse uterine fibromatosis - two
different entities - a prospective study. Archives of
the Balkan Medical Union. vol. 51, no. 1, pp. 12-17.
Copyright © 2016 CELSIUS March 2016.
[5] Klatsky PC, Tran ND, Caughey AB, Fujimoto
VY. Fibroids and reproductive outcomes: a
systematic literature review from conception to
delivery. Am J Obstet Gynecol. 2008;198(4):357-
366.
[6] Bosteels J, Kasius J, Weyers S, Broekmans FJ,
Mol BW, D’Hooghe TM. Hysteroscopy for treating.
subfertility associated with suspected major uterine
cavity abnormalities. Cochrane Database Syst Rev.
2013;(1):CD009461. PMID: 23440838.
[7] Achache H, Revel A. Endometrial receptivity
markers, the journey to successful embryo
implantation. Hum Reprod Update. 2006;12(6):731-
746.
[8] Deborah E. Ikhena, Serdar E. Bulun. Literature
Review on the Role of Uterine Fibroids in
Endometrial Function. Reproductive Science. Issue
published: May 1, 2018, Volume: 25 issue: 5, page(s):
635-643.
https://doi.org/10.1177/1933719117725827.
[9] Du, H. and Taylor, H.S. The role of Hox genes in
female reproductive tract development, adult
runction, and fertility. Cold Spring Harb Perspect
Med. 2015; 6: a023002.
[10] Taylor, H.S., Igarashi, P., Olive, D.L., and Arici,
A. Sex steroids mediate HOXA11 expression in the
human peri-implantation endometrium. J Clin
Endocrinol Metab. 1999; 84: 1129–1135.
[11] Bagot, C.N., Troy, P.J., and Taylor, H.S.
Alteration of maternal Hoxa10 expression by in vivo
gene transfection affects implantation. Gene Ther.
2000; 7: 1378–1384.
[12] Dey SK, Lim H, Das SK, et al. Molecular clues
to implantation. Endocr Rev. 2004;25(3):341-373.
[13] Pollard JW, Hunt JS, Wiktor J, Stanley ER.
1991. A pregnancy defect in the osteopetrotic (op/op)
mouse demonstrates the requirement for CSF-1 in
female fertility. Dev Biol.14: 273–283.
[14] Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi
I, Kontgen F, Abbondanzo SJ 1992 Blastocyst
implantation depends on maternal expression of
leukaemia inhibitory factor. Nature 359:76–79.
[15] Robb L, Li R, Hartley L, Nandurkar HH,
Koentgen F, Begley CG 1998 Infertility in female
mice lacking the receptor for interleukin 11 is due to
a defective uterine response to implantation. Nat Med
4:303–308.
[16] Song H, Lim H, Das SK, Paria BC, Dey SK 2000
Dysregulation of EGF family of growth factors and
COX-2 in the uterus during the preattachment and
attachment reactions of the blastocyst with the
luminal epithelium correlates with implantation
failure in LIF-deficient mice. Mol Endocrinol
14:1147–1161.
[17] Chakraborty I, Das SK, Dey SK 1995
Differential expression of vascular endothelial
growth factor and its receptor mRNAs in the mouse
uterus around the time of implantation. J Endocrinol
147:339–352.
[18] Paria BC, Ma W, Tan J, Raja S, Das SK, Dey
SK, Hogan BL 2001 Cellular and molecular
responses of the uterus to embryo implantation can be
elicited by locally applied growth factors. Proc Natl
Acad Sci USA 98:1047–1052.
Published
2020-09-01
How to Cite
[1]
F. Calin, “THE IMPACT OF UTERINE FIBROMATOSIS ON THE ENDOMETRIUM AND FERTILITY”, JSS, vol. 7, no. 2, pp. 45-51, Sep. 2020.
Section
Articles